Drug research

SPR001

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal HyperplasiaNCT03687242	Spruce Biosciences	Phase 2	Completed	2019-07-08Actual
Study of SPR001 in Adults With Classic Congenital Adrenal HyperplasiaNCT03257462	Spruce Biosciences	Phase 2	Completed	2019-03-02Actual

Spruce BiosciencesCompletedPrimary completion: 2019-07-08 · Actual

Trial details

Spruce BiosciencesCompletedPrimary completion: 2019-03-02 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.